2 hours ago
A seasoned business strategist with over a decade of experience in digital transformation and startup scaling.
Latest Updates
Featured Posts
Get in Touch
Location:
123 Innovation Street
Tech District, CA 94105
123 Innovation Street
Tech District, CA 94105
Email:
[email protected]
[email protected]
Phone:
+1 (234) 567-890
+1 (234) 567-890
US and UK Establish No-Tariff Accord on Prescription Drugs.
The United Kingdom and the United States have concluded a important commercial pact that will ensure zero import taxes on British pharmaceutical shipments entering the American market.
The Terms of the Pact
As part of the deal, the UK has pledged to increase funding on medicines through the NHS. This commitment ensures that duties on these vital products will stay at nothing for a period of 36 months.
This deal follows previous threats to significantly raise import taxes on patented pharmaceutical products, with increases discussed reaching 100%.
"This agreement between the Britain bolsters the worldwide climate for new treatments and establishes much-needed balance to U.S.–U.K. pharmaceutical trade," a statement declared.
Trade Significance
Medicines constitute one of the UK's biggest export categories to the America, which is easily the primary destination for leading British pharmaceutical firms.
Trade data show that in the 12 months leading up to last September, the UK exported medicines worth over eleven billion pounds to the US. This value made up nearly one-fifth of British export trade in that timeframe.
"This agreement secures employment, stimulates investment and paves the way for the UK to become a international leader for life sciences," the Business and Trade Secretary stated.
Detailed UK Commitments
The deal involves several specific changes from the United Kingdom:
- Higher Cost Ceiling: The UK will lift the affordability limit at which it deems new treatments to be unaffordable by twenty-five percent.
- Increased NHS Spending: There is a target to increase overall NHS spending on drugs from 0.3 percent of GDP to 0.6% over the coming ten years.
- Payback Limit: The sum manufacturers must pay back to the NHS to prevent overspending will be restricted at 15%. Last year, refunds exceeded twenty percent.
Industry Background
The pact comes amid a ongoing tension between the sector and the British authorities over drug pricing and NHS adoption.
These tensions were heightened by claims that American patients were charged significantly more for the same drugs than patients in the UK and Europe.
Over the last 18 months, several major drug company projects in the UK have been halted or scrapped, while substantial funding commitments have been announced toward US facilities.
The Science Minister stated that the NHS must invest a greater share on drugs, noting that its budget allocation on drugs had declined as a percentage of its overall budget over the past decade.
Jennifer Hernandez
Sponsored News
News
News
News
News
Colombian President Declares 'I Would Return to Arms Once More' if American Forces Intervenes Militarily.
Jennifer Hernandez
03 Oct 2026
News
News